{"product_id":"the-patient-equation-isbn-9781119622147","title":"The Patient Equation","description":"\u003cp\u003e\u003cb\u003eHow the data revolution is transforming biotech and health care, especially in the wake of COVID-19—and why you can’t afford to let it pass you by\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWe are living through a time when the digitization of health and medicine is becoming a reality, with new abilities to improve outcomes for patients as well as the efficiency and success of the organizations that serve them. In \u003ci\u003eThe Patient Equation\u003c\/i\u003e, Glen de Vries presents the history and current state of life sciences and health care as well as crucial insights and strategies to help scientists, physicians, executives, and patients survive and thrive, with an eye toward how COVID-19 has accelerated the need for change. One of the biggest challenges facing biotech, pharma, and medical device companies today is how to integrate new knowledge, new data, and new technologies to get the right treatments to the right patients at precisely the right times—made even more profound in the midst of a pandemic and in the years to come.\u003c\/p\u003e \u003cp\u003eDrawing on the fascinating stories of businesses and individuals that are already making inroads—from a fertility-tracking bracelet changing the game for couples looking to get pregnant, to an entrepreneur reinventing the treatment of diabetes, to Medidata's own work bringing clinical trials into the 21st century—de Vries shares the breakthroughs, approaches, and practical business techniques that will allow companies to stay ahead of the curve and deliver solutions faster, cheaper, and more successfully—while still upholding the principles of traditional therapeutic medicine and reflecting the current environment.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eHow new approaches to cancer and rare diseases are leading the way toward precision medicine\u003c\/li\u003e \u003cli\u003eWhat data and digital technologies enable in the building of robust, effective disease management platforms\u003c\/li\u003e \u003cli\u003eWhy value-based reimbursement is changing the business of life sciences\u003c\/li\u003e \u003cli\u003eHow the right alignment of incentives will improve outcomes at every stage of the patient journey\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWhether you're a scientist, physician, or executive, you can't afford to let the moment pass: understand the landscape with this must-read roadmap for success—and see how you can change health care for the better.\u003c\/p\u003e \u003cp\u003eIntroduction vii\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1 From Hippocrates to Epocrates 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 1 Before We Cured Scurvy 3\u003c\/p\u003e \u003cp\u003eChapter 2 Inside the Equations 17\u003c\/p\u003e \u003cp\u003eChapter 3 Fitbits, Smart Toilets, and a Bluetooth-enabled Self-driving ECG 43\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2 Applying Data to Disease 57\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 4 Ava—Tracking Fertility, on the Road Toward Understanding All of Women’s Health 59\u003c\/p\u003e \u003cp\u003eChapter 5 One Breath, One Drop—Asthma and Diabetes, Chronic Conditions Being Conquered with Technology 69\u003c\/p\u003e \u003cp\u003eChapter 6 Flumoji and Sepsis Watch—Two Approaches to Predicting and Preventing Acute, Life-threatening Conditions Through Smarter Data 81\u003c\/p\u003e \u003cp\u003eChapter 7 Cancer and Phage Therapy—Crafting Custom Treatments Just for You 93\u003c\/p\u003e \u003cp\u003eChapter 8 Castleman Disease—Not One Rare Disease with No Treatments, But Three Rare Diseases . . . with Hope, Thanks to Data 105\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3 Building Your Own Patient Equations 113\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 9 The Steam Table 115\u003c\/p\u003e \u003cp\u003eChapter 10 Good Data 133\u003c\/p\u003e \u003cp\u003eChapter 11 Changing Clinical Trials 143\u003c\/p\u003e \u003cp\u003eChapter 12 Disease Management Platforms 175\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 4 Scaling Progress to the World 191\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 13 The Importance of Collaboration 193\u003c\/p\u003e \u003cp\u003eChapter 14 Value-based Reimbursement 203\u003c\/p\u003e \u003cp\u003eChapter 15 Aligning Incentives 217\u003c\/p\u003e \u003cp\u003eConclusion 231\u003c\/p\u003e \u003cp\u003eAcknowledgments 241\u003c\/p\u003e \u003cp\u003eAbout the Authors 243\u003c\/p\u003e \u003cp\u003eIndex 245\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eGLEN DE VRIES\u003c\/b\u003e is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen has been driving Medidata's mission since the company's inception in 1999, \"powering smarter treatments and healthier people\" by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen's work has appeared in \u003ci\u003eApplied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics\u003c\/i\u003e, and other journals. He also serves as a trustee of Carnegie Mellon University. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eJEREMY BLACHMAN\u003c\/b\u003e is a writer who works with leaders across industries on getting their ideas out to the world. He has published two novels and developed television pilots for NBC. His writing has appeared in \u003ci\u003eThe New York Times\u003c\/i\u003e, \u003ci\u003eThe Wall Street Journal\u003c\/i\u003e, and many other prominent publications.  \u003c\/p\u003e\u003cp\u003eWe are in the midst of a biological and technological revolution in which the digitization of health and medicine is becoming a reality. Everyone across the industry spectrum—life science and technology companies, hospitals and health care providers, biotech researchers and entrepreneurs—is making significant progress applying data to health and disease, attempting to match the right treatments to the right patients at the right times and dramatically enhance quality of life—and COVID-19 has further illustrated the need for change. From apps and wearables to entirely new approaches to clinical trials, digital technologies are transforming every aspect of the industry. \u003ci\u003eThe Patient Equation\u003c\/i\u003e examines the history, current status, and future role of data in health care and life sciences, with an eye toward what ought to be on the minds of business leaders, scientists, physicians, policy makers, stakeholders, and patients.\u003c\/p\u003e \u003cp\u003eDrawing from his two decades of practical experience and leadership in the life sciences industry, author Glen de Vries explains what you need to understand in order to succeed in this rapidly-changing landscape. Featuring real-life stories of businesses and individuals already making incredible progress applying data and analytics to help solve a range of conditions, this book illustrates the business necessity of staying ahead of the technology curve and combining data-driven precision medicine with the traditional principles of therapeutic health care.\u003c\/p\u003e \u003cp\u003eAs data-driven precision medicine continues to transform the way treatments are developed, delivered, and applied, understanding digital technologies is critical for everyone in the business of health care. Whether you're an industry leader, health care practitioner, or simply a person looking to live a longer, healthier life, \u003ci\u003eThe Patient Equation\u003c\/i\u003e will help you seize the opportunity to take full advantage of the present breakthroughs and understand how the future is set to unfold.\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eHOW TO EMBRACE THE DATA REVOLUTION TO DELIVER FASTER, CHEAPER, AND MORE EFFECTIVE SOLUTIONS IN LIFE SCIENCES AND HEALTH CARE\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eDigital transformation is changing the business of health care at breakneck speed—accelerated even further in the wake of COVID-19. Across the industry, from biotech and pharmaceutical companies to hospital systems, insurers, and more, everyone is looking for the next big technological innovations to develop new treatments, enhance care, improve outcomes, maximize efficiency, and increase value in our data-powered world. How did we get here, and what does the future hold?  \u003c\/p\u003e\u003cp\u003e\u003ci\u003eThe Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond\u003c\/i\u003e explores the history, current state, and future direction of the use of data in biotechnology and health care. Author Glen de Vries, co-founder of the leading cloud platform for life sciences research, shares his insights and leadership on precision medicine and the digital landscape of the future. Designed to help anyone in the business of life sciences navigate our complex world, this practical guide explains the principles, approaches, and business models that are crucial for keeping pace with the ongoing revolution in data and analytics. Throughout the book, real-life stories show you what individuals and organizations are doing to ensure the data revolution does not pass them by, from wearables to track fertility to apps to conquer diabetes, from AI-powered sepsis alerts to using breakthrough new data strategies in clinical trials.  \u003c\/p\u003e\u003cp\u003eA must-have resource for anyone interested in the future of life sciences and health care, \u003ci\u003eThe Patient Equation:\u003c\/i\u003e \u003c\/p\u003e\u003cul\u003e \u003cli\u003eCovers the world of precision medicine, from the individual patient to the global population\u003c\/li\u003e \u003cli\u003eExplains the fundamentals of patient equations and data collection and analysis\u003c\/li\u003e \u003cli\u003eDiscusses current progress and the most effective strategies to achieve future breakthroughs\u003c\/li\u003e \u003cli\u003eExamines approaches to predicting and preventing disease using smart data\u003c\/li\u003e \u003cli\u003eIllustrates why value-based reimbursement is the model of the future\u003c\/li\u003e \u003cli\u003eDescribes how data and technology will help us conquer everything from chronic conditions to cancer to rare diseases to pandemic illness\u003c\/li\u003e \u003c\/ul\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47990307520741,"sku":"NP9781119622147","price":30.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119622147.jpg?v=1761787291","url":"https:\/\/k12savings.com\/products\/the-patient-equation-isbn-9781119622147","provider":"K12savings","version":"1.0","type":"link"}